Studies on pharmacological inhibition of various viral diseases have shown that inhibition of Caspase-1 could block the GSDMD-mediated cell pyroptosis process and reduce the expression levels of IL-1β and IL-18, leading to corresponding therapeutic effects on viral diseases. Here, GSDMD is linked to viral load.